Should You Buy Aehr Test Systems (AEHR) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
AEHR is NOT a good buy right now for a beginner, long-term investor with $50k–$100k who is impatient and doesn’t want to wait for an ideal entry. Despite a bullish near-term technical setup and bullish options positioning, the latest quarter shows weakening demand (revenue down sharply) and a major gross-margin decline, and management guidance was cut. The better decision today is HOLD/avoid new buying until bookings and revenue re-accelerate and margins stabilize.
Technical Analysis
Price/Trend: Pre-market is ~$28.7 (+3.42%) vs prior close context around ~$27.75. Trend structure is bullish on moving averages (SMA_5 > SMA_20 > SMA_200), which typically supports further upside follow-through.
Momentum: MACD histogram is positive (0.179) but “positively contracting,” implying bullish momentum is fading rather than strengthening. RSI(6) ~52.6 is neutral—no strong overbought/oversold signal.
Levels: Pivot ~28.451. If price holds above the pivot, the next resistance is R1 ~30.861 (then R2 ~32.35). If the move fails, support sits at S1 ~26.042 (then S2 ~24.553).
Pattern-based short-term bias (from similar candlesticks): Model indicates ~70% chance of only a small +0.62% next day, but expects -3.29% over the next week and -4.67% over the next month—suggesting the current bounce may not translate into sustained near-term gains.
Analyst Ratings and Price Target Trends
Recent trend: Mixed. One new bullish initiation (Lake Street, Buy, $29 PT on 2025-12-17) was followed by a more cautious update (Craig-Hallum, Hold, PT cut to $21 from $24 on 2026-01-09) after weaker results and reduced guidance.
Wall Street pros view:
Pros: Unique wafer-level test/burn-in positioning; potential multi-year demand tailwinds from AI/HPC reliability requirements and expanded TAM.
Cons: Near-term execution/demand risk is elevated (recent guidance cut), and margin compression is significant—making timing unfavorable for a beginner long-term investor who wants to buy “now” without waiting.
Wall Street analysts forecast AEHR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AEHR is 25 USD with a low forecast of 21 USD and a high forecast of 29 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast AEHR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AEHR is 25 USD with a low forecast of 21 USD and a high forecast of 29 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 27.980
Current: 27.980
